fbpx

1.800.597.1870

Free Case Evaluation

Terms and Conditions

Legal Notices, Disclaimers, Terms and Conditions:

IMPORTANT: Please read these Legal Notices and Terms of Use (these “Notices and Terms”) carefully before accessing this website.

These Notices and Terms create a legal agreement between you (“You”) and DrugLawJournal.com (“DrugLawJournal” or “we”) that governs: (1) the information of DrugLawJournal.com (the “Information”) made available through this website; (2) the nature of the relationship between You and DrugLawJournal.com; (3) certain other matters of professional responsibility; (4) DrugLawJournal.com’s use of Your information gathered by it through this website; and (5) Your use of this website, related systems, and the Information (collectively, the “DrugLawJournal.com Site”). By accessing any portion of the DrugLawJournal.com Site, You are indicating that You have read and understood, and that You assent to be bound by, these Notices and Terms, which may be amended from time to time without any notice to You by DrugLawJournal.com pursuant to the terms herein. Any changes are effective upon posting, and You are responsible for regularly reviewing these Terms. If You do not agree to these Notices and Terms, You are not permitted to access the DrugLawJournal.com Site and if the terms change and You do not agree to these Terms, Your sole remedy is to discontinue use of the DrugLawJournal.com Site.

1) Terms of Use

  1. a) Legal Disclaimers
  2. i) No Legal Advice: The Information is made available for general informational purposes only, and is not intended to constitute specific legal advice or to be a substitute for advice from qualified counsel. The Information may not apply to Your specific situation or jurisdiction or may be incomplete. Although we may update certain Information on the DrugLawJournal.com Site, some of the Information may be outdated. You should not act or refrain from acting or rely on any Information on the DrugLawJournal.com Site and should seek the advice of an attorney before taking any action.
  3. ii) No Tax Advice (Required Tax Disclosure – Circular 230): Any tax information presented on the DrugLawJournal.com Site is not intended to constitute a complete analysis of all tax considerations. Internal Revenue Service regulations generally provide that, for the purpose of avoiding United States federal tax penalties, a taxpayer may rely only on formal written opinions meeting specific regulatory requirements. The information presented on the DrugLawJournal.com Site does not meet those requirements. Accordingly, such information is not intended or written to be used, and a taxpayer cannot use it, for the purpose of avoiding United States federal or other tax penalties or for the purpose of promoting, marketing or recommending to another party any tax-related matters.

iii) No Attorney-Client Relationship: You agree that Your access of the DrugLawJournal.com Site or receipt of the Information, or Your transmission of electronic mail to addresses on the DrugLawJournal.com Site, does not create an attorney-client relationship between You and DrugLawJournal.com. If You communicate with us through the DrugLawJournal.com Site, Your communication may not be treated as privileged or confidential. DrugLawJournal.com does not enter into attorney-client relationships.  Its sponsor firm has a policy of entering into attorney-client relationships with its clients only in accordance with certain procedures which include executing an engagement letter and addressing any and all potential or actual professional responsibility conflicts as required by the applicable Bar Associations.

b) Advertising Notice:

The DrugLawJournal.com Site is not intended to be an advertisement or solicitation, but may be deemed an ADVERTISEMENT in certain jurisdictions. Through the DrugLawJournal.com Site, DrugLawJournal.com and its legal sponsor do not seek to be retained by anyone in a state where the DrugLawJournal.com Site may fail to comply with all laws and ethical rules of that state. Before making Your choice of attorney, You should give this matter careful thought. The selection of a lawyer is an important decision that should not be based solely upon written information about our sponsor’s qualifications and experience. DrugLawJournal.com has endeavored to comply with all known legal and ethical requirements in compiling the DrugLawJournal.com site. DrugLawJournal.com does not represent clients.  The sponsors of DrugLawJournal.com do not desire to represent clients based upon their review of any portions of the DrugLawJournal.com site that do not comply with legal or ethical requirements.

c) Sensitive Communications:

You agree that electronic mail sent by You to DrugLawJournal.com will not be treated as confidential or invoke an attorney-client privilege.  You acknowledge that electronic mail and the Internet are generally insecure media of communication, and DrugLawJournal.com cannot guarantee the confidentiality of any electronic mail sent to or received by it or any information submitted by You to DrugLawJournal.com through the DrugLawJournal.com Site.

d) Conduct:

You agree that You will not use the DrugLawJournal.com Site for any purpose that is unlawful or which could interfere with or impair the operation and functionality of the site. You further agree that, when using the DrugLawJournal.com Site, You will refrain from emailing or otherwise transmitting:

  1. i) copyrighted material of which You are not the copyright owner;
  2. ii) information that will breach applicable laws or regulations, including data protection or privacy laws;

iii) material which is damaging, threatening, abusive, harassing, discriminatory or defamatory in nature or which another user of our website may find objectionable;

  1. iv) viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful; or
  2. v) content that You do not have the right to submit under any law or which would put You in breach of a contractual or fiduciary obligation (for example, confidential information learned or acquired during the course of Your employment with us or information that would infringe confidentiality rights).

As a further condition of Your use of our website, You agree that You will not:

  1. i) impersonate any entity or organization or misrepresent Your affiliation with any person or organization; or
  2. ii) advertise, sell, offer to sell or buy goods or services or engage in solicitation or promotional activity, except in those areas of our website that have been specifically designated for such purposes.

In addition to the above, You agree that You are bound by, and will comply with, all local laws, regulations and rules to which You are subject and which regulate Your use of the Internet.

f) Proprietary Rights

  1. i) Our Intellectual Property Rights. The materials on the DrugLawJournal.com Site, including without limitation any and all text, software, scripts, graphics, photos, sounds, music, videos, interactive features and the like and the trademarks, service marks and logos contained therein, are owned by DrugLawJournal.com, licensed to DrugLawJournal.com, or used by permission subject to copyright and other intellectual property rights under United States and foreign laws and international conventions. Any use of these materials by You shall be in accordance with these statutes and laws. Nothing contained on the DrugLawJournal.com Site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use the DrugLawJournal.com Site or any content displayed on the DrugLawJournal.com Site, through the use of framing or otherwise, without the prior written permission of DrugLawJournal.com or such third party that may own the trademark or copyright of material displayed on this Site. All names, logos and trademarks owned by or licensed to DrugLawJournal.com and are set off from surrounding text, and are referred to with a ™ or ® symbol or appear in italics or all capital letters. All other trademarks displayed on the DrugLawJournal.com Site are trademarks of their respective owners. All other trademarks displayed on the DrugLawJournal.com Site are trademarks of their respective owners. Such third party trademarks are used only to identify the products and services of their respective owners, and no sponsorship or endorsement on the part of DrugLawJournal.com should be inferred from the use of these trademarks. Nothing contained in the DrugLawJournal.com Site should be construed as granting any license or right of use of any trademark displayed on the DrugLawJournal.com Site without the express written permission of DrugLawJournal.com or the third party owner. DrugLawJournal.com logos, service marks and trademarks are trademarks of DrugLawJournal.com (the “DrugLawJournal.com Marks”). Without DrugLawJournal.com’ prior permission, You agree not to display or use in any manner, the DrugLawJournal.com Marks.
  2. ii) Use of the DrugLawJournal.com Site. Only for Your personal, non-commercial and informational purposes, and subject to these Terms, You may (a) access and view the DrugLawJournal.com Site and its materials, and (b) make a limited number of prints, downloads and copies of the documents made available on the DrugLawJournal.com Site, provided that You maintain all copyright and other notices in print outs or downloads on all copies. Any other use (and in particular, any commercial use) of the DrugLawJournal.com Site or its contents is not permitted. Except as expressly authorized by DrugLawJournal.com, You agree not to modify, rent, lease, loan, sell, distribute or create derivative works based on the DrugLawJournal.com Site or Materials in whole or in part. You are not permitted to use any automated means of compiling e-mail addresses from the DrugLawJournal.com Site for the purpose of sending unsolicited commercial emails. Any rights not expressly granted herein are reserved.

iii) Linking to the Site. You may hyperlink to the home page of the DrugLawJournal.com Site, but You may not frame or mirror the DrugLawJournal.com Site or use any meta tags or any other “hidden text” using DrugLawJournal.com’ name or trademarks. You must remove any hyperlink to the DrugLawJournal.com Site upon DrugLawJournal.com’ request.

  1. iv) Permission Requests. Please contact DrugLawJournal.com at (800) 597-1870 and ask for the Administration lead if You wish to request permission to use any materials of the DrugLawJournal.com Site in a manner not authorized above.

g) Registration Obligations:

  1. i) Registration. The DrugLawJournal.com Site may allow You to register in order to personalize Your viewing of content on the site and to receive certain publications from DrugLawJournal.com. In registering, You agree to provide complete and accurate information about Yourself. You are responsible for maintaining the confidentiality of Your username and password and You accept responsibility for all activities that occur under Your username and password.
  2. ii) Termination. DrugLawJournal.com reserves the right to change the DrugLawJournal.com Site, including its contents, and to block or terminate access to or use of the DrugLawJournal.com Site, including through usernames and passwords, at any time for any reason and without notice.

h) Third Party Sites:

Any links on the DrugLawJournal.com Site to third party sites are provided solely as a convenience to You and are not intended to state or imply that DrugLawJournal.com sponsors, or is affiliated or associated with, the linked sites. Your privacy and conditions of Your use at those websites are governed by the privacy policy and terms of use at that website and not DrugLawJournal.com’ policies and terms.

i) Disclaimer of Warranties:

YOU ACKNOWLEDGE AND AGREE THAT THE DrugLawJournal.com SITE, INCLUDING THE INFORMATION PROVIDED THROUGH THE DrugLawJournal.com SITE, IS PROVIDED “AS IS” AND WITHOUT WARRANTIES, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO, NON-INFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR USE OR PURPOSE. DrugLawJournal.com ASSUMES NO LIABILITY OR RESPONSIBILITY FOR ANY ERRORS OR OMISSIONS IN, OR RELIANCE UPON, THE INFORMATION IN THIS WEBSITE. ANY MATERIALS DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE DrugLawJournal.com SITE IS DONE AT YOUR OWN DISCRETION AND RISK. YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OR USE OF ANY SUCH MATERIAL.

j) Disclaimer of Liability.

TO THE EXTENT PERMITTED BY THE LAW AND RULES OF PROFESSIONAL RESPONSIBILITY IN THE APPLICABLE JURISDICTION, DrugLawJournal.com DISCLAIMS LIABILITY FOR ANY LOST PROFITS OR INCOME, LOST BUSINESS, OR LOST DATA, OR FOR ANY CONSEQUENTIAL, INDIRECT, EXEMPLARY, PUNITIVE, SPECIAL, OR INCIDENTAL DAMAGES ARISING FROM OR RELATING TO THE DrugLawJournal.com SITE.

k) Limitations of Liability:

Under no circumstances will any of the DrugLawJournal.com Parties be liable for any loss or damage caused by Your reliance on information obtained through this site. It is Your responsibility to evaluate the accuracy, completeness, or usefulness of this site. In no event shall any of the DrugLawJournal.com Parties be liable for any direct, indirect, punitive, incidental, special or consequential damages arising out of or relating to the site or this agreement, whether based on warranty, contract, tort, or any other legal theory. Because some jurisdictions do not allow the exclusion or limitation of liability for negligence, consequential, incidental or other damages, in such jurisdictions DrugLawJournal.com’ liability is limited to the greatest extent permitted by law. Your sole remedy for dissatisfaction with this site is to stop using this site.

l) Response to Online Requests:

From time to time, DrugLawJournal.com may offer to provide information or materials via electronic mail or otherwise to interested persons. DrugLawJournal.com reserves the right, in its absolute discretion, to reject any requests for such information or materials, or to discontinue the provision of such information or materials to any person, for any reason whatsoever.

m) Indemnity:

You agree to indemnify and hold DrugLawJournal.com, and its subsidiaries, affiliates, officers, agents, partners, and employees, harmless from any claim or demand, including reasonable attorneys’ fees, made by any third party due to or arising out of Your use of the Site, Your connection to the Site, Your violation of the Terms, or Your violation of any rights of another.

n) Electronic Correspondence to the Firm and Affiliated Servers:

While we are happy to have You contact us by telephone, surface mail, electronic mail or facsimile transmission, merely communicating with DrugLawJournal.com or a DrugLawJournal.com staff/employee does not create a lawyer-client relationship.  Any information You convey to DrugLawJournal.com electronically may not be secure, and information conveyed prior to establishing a lawyer-client relationship may not be privileged or confidential.

o) Virus, Hacking and Other Offenses:

You must not attempt to gain unauthorized access to the DrugLawJournal.com Site, the server on which the DrugLawJournal.com Site is stored or any server, computer or database connected to our website. You must not attack our website via a denial-of-service attack or a distributed denial-of service attack. You must not take any action that imposes an unreasonably or disproportionately large load on the website’s infrastructure. You must not use any device, software or routine to interfere or attempt to interfere with the proper working of the website or any activity being conducted on the website. You must not use or attempt to use any engine, software, tool, agent or other device or mechanism (including, without limitation, browsers, spiders, robots, avatar’s or intelligent agents) to navigate or search the website other than the search engine and search agents available from the website and other than generally available third-party web browsers (e.g., Mozilla FireFox and Microsoft Internet Explorer). You must not attempt to decipher, decompile, disassemble or reverse engineer any of the software comprising or in any way making up part of the website.

By breaching this provision, You may commit a criminal offense under applicable laws. We will report any such breach to the relevant law enforcement authorities and we will cooperate with those authorities by disclosing Your identity to them. In the event of such a breach, Your right to use our website will cease immediately.

We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect Your computer equipment, computer programs, data or other proprietary material due to Your use of our website or to Your downloading of any material posted on it, or on any website linked to it.

p) General:

These Terms, including the Privacy Statement along with any other terms and policies posted on the DrugLawJournal.com Site, constitute the entire agreement between You and DrugLawJournal.com regarding Your use of the DrugLawJournal.com Site and supersedes any prior agreements between You and DrugLawJournal.com regarding such use, other than any written agreement between You and DrugLawJournal.com.

q) Miscellaneous:

In the event that any portion of this Agreement is held to be invalid or unenforceable, then such portion shall be construed in accordance with the applicable law as nearly as possible to reflect the original intentions of the parties, and the remainder of this Agreement shall remain in full force and effect. The sections of this Agreement entitled Intellectual Property Rights, Disclaimer, Limitation of Liability, Indemnification, Miscellaneous shall survive the termination of this Agreement. DrugLawJournal.com reserves the right to change, suspend, or discontinue all or any part of this Site or the Content at any time without prior notice or liability. The paragraph headings herein are provided only for reference and shall have no effect on the construction or interpretation of this Agreement. You expressly absolve and release DrugLawJournal.com from any claim of harm resulting from a cause beyond their control, including, but not limited to, failure of electronic or mechanical equipment or communication lines, telephone or other interconnect problems, computer viruses, unauthorized access, theft, operator errors, severe weather, earthquakes, or natural disasters, strikes or other labor problems, wars, terrorist activities or governmental restrictions. You may not assign this Agreement. No waiver shall be effective unless in writing. Neither the course nor conduct between the parties nor trade practice shall act to modify any provision of this Agreement. This Agreement shall be governed by and construed in accordance with the laws of the state of Florida, except with regard to its conflicts or choice of law rules. You shall comply with all laws, rules and regulations which are now or hereinafter promulgated by any government authority or agency which govern or apply to the operation and use of the Site. Without limiting the generality of the foregoing, You expressly agree to comply with such restrictions and not to export control laws of the United States. You are prohibited from any use of the Site that would constitute an illegal offense, give rise to liability or otherwise violate any applicable local, state, national or international law or regulation. All rights not expressly granted herein are reserved by DrugLawJournal.com. This Agreement contains the entire agreement of the parties concerning Your use of this Site and supersedes all existing agreements and all other oral, written or other communication between the parties concerning its subject matter.

 

Drug Law Journal Legal Sponsorship

Drug Law Journal's publishing and research are sponsored by the DDP Injury Law Group in Washington, D.C. Their legal team is focused on protecting the rights of injury victims.
Furthermore, they understand and appreciate the importance of a trusted attorney-client relationship.
The DDP Injury Law Group uses their years of experience with litigation to ensure their clients can fight for the compensation they deserve.

Always seek the advice of a medical professional when making personal health choices.

The Offices of DrugLawJournal.com are located at:

1800 North Orange Avenue, Suite C
Orlando, Florida 32804

DrugLawJournal.com is sponsored by the DDP Injury Law Group, and therefore may be considered attorney advertising. The information contained on DrugLawJournal.com is provided for informational purposes only, and should not be construed as legal or medical advice on any subject matter. No viewers of this site should discontinue taking a prescribed medication on the basis of any information on this site and should always first consult with a doctor concerning any medication. Viewers should understand that if they refrain from taking prescribed medication without appropriate medical advice they can suffer injury or death.

No viewers of content from this site, clients or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or other professional advice on the particular facts and circumstances at issue from an attorney licensed in the viewer’s state. Viewing information from DrugLawJournal.com does not create an attorney-client relationship between you and DDP Injury Law Group or DrugLawJournal.com nor is it intended to do so.The content of DrugLawJournal.com may not reflect current legal developments, verdicts or settlements. Prior results do not predict a similar outcome. For more information, please visit our web site’s disclaimer.

©2024 DrugLawJournal.com | Privacy Policy | Terms & Conditions

Stay Informed

Sign up to receive peroidic updates from our expert team of researchers, highlighting defective drugs, devices, and legal issues related to your health.

Email Catcher
Free Drug and Medical Device Case Review

Free Drug and Medical Device Case Review

Share your story with us and we will reach out to you about your case.

First
Last
Described what happened to you, we will review and reach out to you about your situation.

It is important for those who have suffered injury from dangerous drugs and medical devices to know that they have may have options.

Consumers have the ability to seek legal remedies for their injuries resulting from the negligence of drug and device manufacturers. The first step toward justice and recovery is sharing your story with effective legal counsel. An attorney will help you to better understand the issues and discuss the possibility of compensation for your suffering.

Once you complete the information request above, Drug Law Journal will send the information to a specialist at our legal sponsor’s firm, the DDP Injury Law Group, in Washington, D.C. That specialist will follow-up with you directly to gather further specific information about your case and make an evaluation. If the firm is able to move forward on your case, they will also discuss next steps. Remember – the entire consult and evaluation is free to you. You only need to take the first step to fill out the contact form or call: (800) 597-1870 for immediate assistance.